???pagination.result.count???
???pagination.result.page???
1
Differential cellular expression of organic anion transporting peptides OATP1A2 and OATP2B1 in the human retina and brain: implications for carrier-mediated transport of neuropeptides and neurosteriods in the CNS. , Gao B., Pflugers Arch. July 1, 2015; 467 (7): 1481-1493.
Characterization of SLCO5A1/OATP5A1, a solute carrier transport protein with non-classical function. , Sebastian K., PLoS One. December 9, 2013; 8 (12): e83257.
Raltegravir is a substrate for SLC22A6: a putative mechanism for the interaction between raltegravir and tenofovir. , Moss DM., Antimicrob Agents Chemother. February 1, 2011; 55 (2): 879-87.
Interaction of methotrexate with organic-anion transporting polypeptide 1A2 and its genetic variants. , Badagnani I., J Pharmacol Exp Ther. August 1, 2006; 318 (2): 521-9.
Excretion of fetal biliverdin by the rat placenta-maternal liver tandem. , Briz O., Am J Physiol Regul Integr Comp Physiol. March 1, 2006; 290 (3): R749-56.
Organic anion transporting polypeptides expressed in liver and brain mediate uptake of microcystin. , Fischer WJ., Toxicol Appl Pharmacol. March 15, 2005; 203 (3): 257-63.
Role of organic anion transporter OATP1B1 ( OATP-C) in hepatic uptake of irinotecan and its active metabolite, 7-ethyl-10-hydroxycamptothecin: in vitro evidence and effect of single nucleotide polymorphisms. , Nozawa T., Drug Metab Dispos. March 1, 2005; 33 (3): 434-9.
Rosuvastatin pharmacokinetics in heart transplant recipients administered an antirejection regimen including cyclosporine. , Simonson SG., Clin Pharmacol Ther. August 1, 2004; 76 (2): 167-77.
Organic anion-transporting polypeptides mediate transport of opioid peptides across blood- brain barrier. , Gao B., J Pharmacol Exp Ther. July 1, 2000; 294 (1): 73-9.
Hepatobiliary elimination of certain peptide-mimicking drugs: linear hydrophobic and hydrophilic renin-inhibitors and hydrophobic cyclopeptides. , Ziegler K., J Hepatol. January 1, 1996; 24 Suppl 1 47-52.